Doctors test genetic blueprint to Fine-Tune radiation doses for aggressive breast cancer
NCT ID NCT05528133
Summary
This study is testing a new approach to radiation therapy for triple negative breast cancer. After a lumpectomy, doctors will use a genetic test on the tumor to determine if a patient should receive a standard or a higher dose of radiation. The goal is to see if this personalized approach can better control the cancer while maintaining quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE-NEGATIVE BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
Contact
Contact
-
Morton Plant Hospital - Baycare Health System
RECRUITINGClearwater, Florida, 33756, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.